LDL-cholesterol

临床试验

计划入组 40 人 · 首次发布于 2019 年 7 月 23 日

尚未招募

NCT06626126

Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention

计划入组 1,448 人 · 首次发布于 2024 年 10 月 3 日

Unknown

NCT03975478

Bariatric Surgery and LDL Cholesterol

计划入组 36 人 · 首次发布于 2019 年 6 月 5 日

药物

查看全部 390 →

Biotech

Approved

Inclisiran(Leqvio)

生产企业：Novartis AG

相关疾病：Atherosclerotic Cardiovascular Diseases, Heterozygous Familial Hypercholesterolemia (HeFH)，另有 2 项

Rx

Biotech

Approved

Alirocumab(Praluent)

相关疾病：Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolaemia (HoFH)，另有 4 项

Rx

Small Molecule

Approved

Cholesterol

C₂₇H₄₆O

机构

查看全部 15 →

Guangdong Jiaying Pharmaceutical Co.,Ltd.

China

CHRYSEA LABS, LDA

Portugal

RSOCIALFORM - GERIATRIA, LDA

Portugal

临床试验

Evaluation of a Probiotic on LDL-cholesterol Levels

Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention

Bariatric Surgery and LDL Cholesterol

药物

Inclisiran(Leqvio)

Alirocumab(Praluent)

Cholesterol

机构

Guangdong Jiaying Pharmaceutical Co.,Ltd.

CHRYSEA LABS, LDA

RSOCIALFORM - GERIATRIA, LDA

资讯

FDA Accepts Review of Lerodalcibep for LDL Cholesterol Reduction

Genetic makeup may determine whether low-carb diets raise LDL cholesterol

Low LDL Cholesterol Levels Associated with Reduced Dementia and Alzheimer's Risk